Nuclear Laser Medicine
Nuclear Laser Medicine srl is an Italian in vitro diagnostics company founded in 1984 that develops molecular diagnostic kits, automated instruments, and interpretive software for clinical and research laboratories in infectious disease, genetics, oncology, and HLA testing across Europe and select international markets.
- Company typePrivate
- Founded1984
- HeadquartersPetralia Sottana, Italy
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Nuclear Laser Medicine does
Nuclear Laser Medicine srl (NLM) is an Italian in vitro diagnostics (IVD) company founded in 1984 and headquartered in Settala, Milan, Italy. With 40 years of operating history and a workforce of 11–50 employees, NLM develops, manufactures, and distributes molecular diagnostic kits, reagents, and automated instruments for clinical and research laboratories across infectious disease, genetics, oncology, and HLA testing applications. The company operates as both an OEM manufacturer of proprietary assays and a value-added distributor of complementary partner products in the Italian and broader European market.
NLM's product portfolio spans Real Time PCR kits built on FRET chemistry, fragment analysis kits using Fluorescent ARMS technology, Reverse Dot Blot (RDB) hybridization assays, and the OMNIA LH 75 PRO automated workstation for nucleic acid extraction and PCR setup. The company also operates NGS on! Whole Exome Analysis, a sequencing service line launched in 2024, and maintains a proprietary interpretive software suite including Real Gene, Real-PHARMA, IntRa-Q, and Genetic Fragment Analyzer. Products are sold under trademarks such as Genvinset, CF FAST, and a dedicated HLA kit line, indicating a branded catalog approach across multiple specialty diagnostic segments.
The commercial model combines direct B2B sales of proprietary kits and instruments with distribution partnerships that bring in partner products (DNA Diagnostics, Blackhills Diagnostic Resources, R-biopharm, Panagene, Protrans, BDR, Masmec). Go-to-market is event-driven (MEDICA, Medlab Middle East, ECCMID) and channel-driven, targeting clinical molecular biology labs, medical genetics centers, and clinical microbiology labs. Revenue mechanics rely on consumable and reagent sales tied to instrument placements, supplemented by distribution margins on partner products and a growing international distributor network. NLM holds ISO 9001:2015, ISO 13485:2016/A11:2021, and IVDR 2017/746/UE compliance with CE-IVDR marked products, and participates in UK NEQAS, CF Network, and INSTAND e.V. EQA schemes.
Nuclear Laser Medicine firmographics
Firmographics- Name
- Nuclear Laser Medicine
- Legal name
- Nuclear Laser Medicine srl
- Website
- https://nlm.it
- Company type
- Private
- Founded year
- 1984
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Nuclear Laser Medicine srl is an Italian in vitro diagnostics company founded in 1984 that develops molecular diagnostic kits, automated instruments, and interpretive software for clinical and research laboratories in infectious disease, genetics, oncology, and HLA testing across Europe and select international markets.
- Ownership category
- akta.pro rank
Nuclear Laser Medicine industry classification
Industry- Product category
- Molecular Diagnostics
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)
Keywords
Where Nuclear Laser Medicine is headquartered
LocationHeadquarters
- HQ city
- Petralia Sottana
- HQ country
- Italy
- HQ region
- Europe
Offices1 record
Markets served
Nuclear Laser Medicine business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Others
Revenue model
- Diagnostic Kits and Reagents: Sale of in vitro diagnostic kits for molecular biology testing including Real Time PCR kits, fragment analysis reagents, and reverse dot blot assays for infectious diseases, genetics, oncology, and HLA applications.
- Automated Instruments: Sale and distribution of automated laboratory workstations including the OMNIA LH 75 PRO for nucleic acid extraction and PCR setup.
- Distribution Partnerships: Revenue from distributing partner products in Italy including R-biopharm, DNA Diagnostics, Panagene, Protrans, Blackhills Diagnostics Resources, and Masmec Biomedical products.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
Nuclear Laser Medicine product offering
Product offeringCore offering
Nuclear Laser Medicine develops, manufactures, and distributes in vitro diagnostic kits and reagents for molecular biology laboratories, including Real Time PCR assays, fragment analysis tests, and reverse dot blot hybridization kits covering infectious diseases, genetics, oncology, and HLA applications. The company also produces the OMNIA LH 75 PRO automated workstation for nucleic acid extraction and PCR setup, and serves as the official Italian distributor for multiple international diagnostics manufacturers (DNA Diagnostics, R-biopharm, Panagene, Protrans, Blackhills Diagnostic Resources, Masmec Biomedical).
Product overview
Nuclear Laser Medicine offers an integrated portfolio of in vitro diagnostic solutions centered on the OMNIA LH 75 PRO automated workstation for nucleic acid extraction and PCR setup, complemented by an extensive menu of Real Time PCR, fragment analysis, and reverse dot blot (RDB) diagnostic kits. The product portfolio spans pharmacogenetics (DPYD, UGT1A1 tests for personalized drug therapy), cystic fibrosis (CF FAST, CF FAST Plus, AC023/25, CF Plus, CF del), hemoglobinopathies (Alpha/Beta Globin Tests), hemochromatosis (HFE mutation panels), cardiovascular disease (CVD-6 Multiplex, Factor II/V, MTHFR, PAI-1, ApoE), and infectious diseases (SARS-CoV-2, HCV genotyping/quantification, Chlamydia, CMV, EBV, HSV-1/2, HHV-6, VZV, Enterovirus). The company also distributes third-party products including SMA screening kits, Fragile X tests (Adellgene), and DNA Diagnostics' Hemavision leukemia translocation panels. Quality management is certified to ISO 9001:2015 and ISO 13485:2016 standards.
Differentiator
Problem solved
Functional benefit
Brands
- OMNIA System: Compact workstation for nucleic acid extraction and PCR setup, designed for molecular biology laboratory automation.
- NGS on!®
Products and services
- OMNIA LH 75 PRO Workstation Automated workstation for nucleic acid extraction and PCR setup using magnetic bead-based technology, with bidirectional LIS connectivity, touchscreen interface, and barcode reading. Designed for clinical molecular biology laboratories handling routine and mid-throughput workflows.
- Real Time PCR Diagnostic Kits (FRET Technology) CE-IVDR marked Real Time PCR kits using FRET melting curve analysis covering infectious diseases (Chlamydia trachomatis, CMV, EBV, HSV-1/2, HHV-6, VZV, Enterovirus, SARS-CoV-2), pharmacogenetics (DPYD, UGT1A1), coagulation and thrombophilia (Factor II/V, MTHFR, PAI-1), hemochromatosis (HFE), HCV genotyping, and other applications.
- Reverse Dot Blot (RDB) Strip Assays Strip-based reverse dot blot hybridization kits for detection of alpha and beta thalassemias, thrombophilia (CVD-14 Multiplex), celiac disease HLA typing (CeLia-Type Strip Assay), and other genetic variations. Includes proprietary interpretive software for automated result analysis.
- CF FAST Fragment Analysis Kits Fragment analysis kits using Fluorescent ARMS technology for detection of CFTR gene mutations causing cystic fibrosis, designed for use on automated sequencers with rapid turnaround.
- NGS on! Whole Exome Sequencing Service Whole Exome Sequencing service performed at NLM's laboratory, providing comprehensive genetic profiling for medical genetics applications with interpretation support.
- IntRaFast-Q SMA Screening Kits Real Time PCR kits for newborn screening and carrier screening of Spinal Muscular Atrophy (SMA), including SMN1 exon 7, SMN1 exon 8, and SMN2 copy number detection.
- Hemavision Leukemia Translocation Panels Distributed from DNA Diagnostics (Denmark), the Hemavision 7Q and 28Q kits detect chromosomal translocations and gene rearrangements in leukemia using multiplex PCR with fragment analysis.
- Adellgene Fragile X Test Kit Distributed from Blackhills Diagnostic Resources, the Adellgene kit detects CGG repeat expansions in the FMR1 gene associated with Fragile X syndrome.
- ULTRAPLEX ALLIANCE System Automated nucleic acid extraction and PCR setup system distributed from Masmec Biomedical, designed to support high-throughput molecular diagnostic workflows.
- NLM PPE Face Masks Personal protective equipment face masks produced by NLM, reflecting the company's diversification into medical supplies alongside its diagnostics portfolio.
Quantifiable outcome
- 100% sensitivity and specificity reported for SMA screening kits (IntRaFast-Q)
- +1 more outcomes
Companies that use Nuclear Laser Medicine
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles2 records
Nuclear Laser Medicine technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
Feature6 records
Nuclear Laser Medicine partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- DNA DiagnosticscoreNLM serves as the official Italian distributor for DNA Diagnostics, a Danish company founded in 1992 specializing in PCR and qPCR kit production for clinical and research laboratories. The partnership provides Italian customers with DNA Diagnostics' products including Hemavision 7Q and Hemavision 28Q for leukemia translocation detection using Real Time PCR technology.
- R-biopharmcoreNLM distributes R-biopharm products in Italy. R-biopharm is a German company specializing in clinical diagnostics and food analysis solutions.
- PanagenecoreNLM distributes Panagene products in Italy. Panagene is a Korean company specializing in molecular biology reagents and instruments.
- ProtranscoreNLM distributes Protrans products in Italy. Protrans is a German company specializing in transplantation diagnostics and HLA typing solutions.
- Blackhills Diagnostics Resources (BDR)coreNLM is the official Italian distributor for Blackhills Diagnostics Resources (BDR), a Spanish company. NLM distributes BDR products including the Adellgene Fragile X kit for FMR1 gene analysis. The partnership has been renewed multiple times.
- Masmec BiomedicalminorNLM distributes Masmec Biomedical products in Italy. Masmec Biomedical is an Italian company specializing in biomedical instruments and diagnostics.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Nuclear Laser Medicine competitors and assessment
Company assessmentBroad incumbents
- Bio-Rad Laboratories: Global life science and clinical diagnostics company with a broad molecular diagnostics portfolio including real-time PCR kits and instruments (e.g., CFX96) that NLM products are validated on. Comparable as a larger incumbent offering overlapping IVD menu categories to the same lab customers.
- Cepheid (Danaher): Developer of the GeneXpert fully integrated PCR systems and broad menu of CE-marked molecular diagnostic tests for infectious disease and oncology. Comparable as a larger incumbent in automated molecular IVD workflows targeting the same hospital lab segment NLM addresses.
- QIAGEN: Global leader in sample-preparation and PCR-based molecular diagnostic kits and automation platforms for clinical and research labs. Comparable as a broader incumbent in IVD molecular workflows, including nucleic acid extraction and PCR setup where NLM's OMNIA competes.
- Hologic: Major molecular diagnostics company with a strong menu of women's health and infectious disease PCR assays sold to hospital and reference labs. Comparable as a broader incumbent serving overlapping clinical lab end-markets with CE-IVDR marked molecular kits.
- Fujirebio (H.U. Group Holdings): Japanese-headquartered IVD company producing clinical diagnostics kits and instruments across infectious disease, oncology and genetic testing. Comparable as a broader incumbent with overlapping molecular IVD menu items and CE-IVDR market presence.
Direct peers
- DNA Diagnostics: Danish manufacturer of PCR and qPCR kits for clinical and research laboratories, including leukemia translocation panels (Hemavision). Highly comparable as a small specialist peer, and also an NLM partner whose products NLM distributes in Italy.
- DiaSorin: Italy-based IVD company focused on immunodiagnostics and molecular diagnostics, including reagents, instruments and consumables. Comparable as a domestic Italian IVD peer with an established international footprint and similarly hospital- and lab-focused channels.
- AB Analitica: Italian IVD manufacturer focused on molecular diagnostics kits, including real-time PCR assays for infectious disease and genetic testing. Closely comparable as a small Italy-headquartered competitor serving the same clinical lab customer base with overlapping menus.
- R-biopharm: German clinical diagnostics manufacturer producing PCR and immunoassay kits for infectious disease and food/clinical analysis. Directly comparable as a same-tier European IVD kit specialist, and NLM is already an Italian distributor for R-biopharm products.
- ELITechGroup: European-headquartered specialist in clinical molecular diagnostics IVD kits and instruments serving hospital and independent laboratories. Closely comparable to NLM in scale, menu breadth across infectious disease and genetic testing, and distribution-led commercial model.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Nuclear Laser Medicine social profiles
Digital presenceNuclear Laser Medicine compliance and trust
Trust signalCompliance6 records
Nuclear Laser Medicine financial estimates
Financial estimateRevenue estimate
Valuation estimate
Nuclear Laser Medicine leadership team
Management profileNumber of profiles
Nuclear Laser Medicine funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Nuclear Laser Medicine M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Nuclear Laser Medicine
What does Nuclear Laser Medicine do?
Nuclear Laser Medicine develops, manufactures, and distributes in vitro diagnostic kits and reagents for molecular biology laboratories, including Real Time PCR assays, fragment analysis tests, and reverse dot blot hybridization kits covering infectious diseases, genetics, oncology, and HLA applications. The company also produces the OMNIA LH 75 PRO automated workstation for nucleic acid extraction and PCR setup, and serves as the official Italian distributor for multiple international diagnostics manufacturers (DNA Diagnostics, R-biopharm, Panagene, Protrans, Blackhills Diagnostic Resources, Masmec Biomedical).
Is Nuclear Laser Medicine a public or private company?
Nuclear Laser Medicine is a private company. It is classified as unknown and is currently operating.
When was Nuclear Laser Medicine founded?
Nuclear Laser Medicine was founded in 1984. It employs 11 to 50 people.
Where is Nuclear Laser Medicine based?
Nuclear Laser Medicine is headquartered in Petralia Sottana, Italy, in the Europe region.
How does Nuclear Laser Medicine make money?
Three revenue lines are on record. Diagnostic Kits and Reagents are the primary driver. The others are automated Instruments and distribution Partnerships.
Who are Nuclear Laser Medicine's main competitors?
Broad incumbents on record are Bio-Rad Laboratories, Cepheid (Danaher), QIAGEN, Hologic and Fujirebio (H.U. Group Holdings). Direct peers are DNA Diagnostics, DiaSorin, AB Analitica, R-biopharm and ELITechGroup.
Does Nuclear Laser Medicine have an API?
No public API is recorded for Nuclear Laser Medicine.
What industry is Nuclear Laser Medicine in?
Nuclear Laser Medicine's product category is Molecular Diagnostics. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes). Its NAICS code is 325413 and its SIC code is 2835.